Managing the Cycle: Unlocking Growth in the United States Premenstrual Syndrome Treatment Market | Top Companies - Haleon, Bayer, Eli Lilly, GSK

Market Size and Growth

According to DataM Intelligence, the US premenstrual syndrome treatment market size reached US$ 598.48 Million in 2024 from US$ 577.29 Million in 2023 and is expected to reach US$ 852.63 Million by 2033, growing at a CAGR of 4.1% during the forecast period 2025-2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/premenstrual-syndrome-treatment-market?sb

Key Development:

✅ In May 2025, Shionogi Inc. announced a simplified absorption-type split to acquire the pharmaceutical business of Japan Tobacco Inc., including all issued shares of Akros Pharma Inc. (US-based), making it a subsidiary. This expands Shionogi's pharmaceutical footprint, potentially enabling scaling in therapeutic areas such as mood and hormonal disorders.

✅ In February 2025, Bain Capital acquired Mitsubishi Tanabe Pharma (Japan) in a carve-out transaction from Mitsubishi Chemical, valued at around USD 3.3 billion. The deal strengthens MTPC's R&D in CNS (central nervous system), immunology, and inflammation, which could influence future therapies for PMS/PMDD.

✅ In January 2025, Fukushima Medical University Hospital began recruiting for a clinical study (registered as jRCTs022240054) evaluating a smartphone app for patients with PMS or PMDD.

✅ In January 2025, ASKA Pharmaceutical and Susmed initiated a clinical study of a therapeutic smartphone app for PMS/PMDD, to assess its efficacy and safety.

Key Players:

=> Major companies working towards the market's growth include Haleon Group, Bayer, Eli Lilly and Company, GSK, Lundbeck A/S, Pfizer Inc., AstraZeneca, Novartis International AG, and MetP Pharma AG, among others.

Growth Forecast Projected:

The Global Premenstrual Syndrome (PMS) Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Premenstrual Syndrome (PMS) Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=premenstrual-syndrome-treatment-market

Key Segments:

➥ By Drug Type: Analgesics & NSAIDs, Antidepressants, Oral Contraceptives, Ovarian Suppression Agents, Gonadotropin-Releasing Hormone (GnRH) Analogues, Selective Serotonin Reuptake Inhibitors (SSRIs), Others
➥ By Indication: Mild-to-Moderate PMS, Severe PMS
➥ By Distribution Channel: Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies

Regional Analysis for Premenstrual Syndrome (PMS) Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Premenstrual Syndrome (PMS) Treatment producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Premenstrual Syndrome (PMS) Treatment revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/premenstrual-syndrome-treatment-market?sb

FAQ

What is the current size of the Premenstrual Syndrome (PMS) Treatment Market?

A: In 2024, the Premenstrual Syndrome (PMS) Treatment Market was valued at US$ 598.48 Million, reflecting its strong industry presence.

Q2: How large is the Premenstrual Syndrome (PMS) Treatment Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Premenstrual Syndrome (PMS) Treatment Market will grow to around US$ 852.63 Million , demonstrating significant expansion.

Q3: What is the growth rate of the Premenstrual Syndrome (PMS) Treatment Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 4.1% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are a one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages among others.
Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across 10 major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market, and by providing a complete view of the market with statistical forecasts. Our strategy-centric framework and value-added services will let individuals and corporates with ease of access and custom personalization to research and markets.

This release was published on openPR.